Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis.
about
Low-density lipoprotein receptor-related protein 1 prevents early atherosclerosis by limiting lesional apoptosis and inflammatory Ly-6Chigh monocytosis: evidence that the effects are not apolipoprotein E dependentPromising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapyApolipoprotein E COG 133 mimetic peptide improves 5-fluorouracil-induced intestinal mucositis.Apolipoprotein E-mimetics inhibit neurodegeneration and restore cognitive functions in a transgenic Drosophila model of Alzheimer's diseaseMacrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation.The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis.An apolipoprotein E-mimetic stimulates axonal regeneration and remyelination after peripheral nerve injury.The apoE-mimetic peptide, COG1410, improves functional recovery in a murine model of intracerebral hemorrhage.Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a reviewThe apolipoprotein E-mimetic peptide COG112 inhibits NF-kappaB signaling, proinflammatory cytokine expression, and disease activity in murine models of colitis.Apolipoproteins in the brain: implications for neurological and psychiatric disorders.Targeting SET/I(2)PP2A oncoprotein functions as a multi-pathway strategy for cancer therapyApolipoprotein E isoform-dependent dendritic recovery of hippocampal neurons following activation of innate immunity.Cross-talk between apolipoprotein E and cytokinesSET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target.Inhibition of Interleukin-10 Signaling Induces Microbiota-dependent Chronic Colitis in Apolipoprotein E Deficient Mice.The apolipoprotein E-mimetic peptide COG112 inhibits the inflammatory response to Citrobacter rodentium in colonic epithelial cells by preventing NF-kappaB activation.Identification of differentially expressed proteins in experimental autoimmune encephalomyelitis (EAE) by proteomic analysis of the spinal cord.Apolipoprotein E and neurological disease: therapeutic potential and pharmacogenomic interactions.Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities.Ocular HSV-1 latency, reactivation and recurrent disease.Inhibition of native and recombinant nicotinic acetylcholine receptors by the myristoylated alanine-rich C kinase substrate peptide.ApoE deficiency promotes colon inflammation and enhances inflammatory potential oxidized-LDL and TNF-α in colon epithelial cells.Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients.Structural determinates for apolipoprotein E-derived peptide interaction with the alpha7 nicotinic acetylcholine receptorCOG1410 improves cognitive performance and reduces cortical neuronal loss in the traumatically injured brainApolipoprotein E mimetics and cholesterol-lowering properties.OP449 inhibits breast cancer growth without adverse metabolic effects.An apolipoprotein E mimetic peptide with activities against multidrug-resistant bacteria and immunomodulatory effects.A new recombinant human apolipoprotein E mimetic peptide with high-density lipoprotein binding and function enhancing activity.APOE genotype alters glial activation and loss of synaptic markers in miceApolipoprotein E Mimetic Promotes Functional and Histological Recovery in Lysolecithin-Induced Spinal Cord Demyelination in Mice.Full-length apolipoprotein E protects against the neurotoxicity of an apoE-related peptideApoE mimetic peptide decreases Abeta production in vitro and in vivo.Low-Density Lipoprotein Receptor Deficiency Attenuates Neuroinflammation through the Induction of Apolipoprotein E.Apolipoprotein E as a novel therapeutic neuroprotection target after traumatic spinal cord injury.The serine protease HtrA1 contributes to the formation of an extracellular 25-kDa apolipoprotein E fragment that stimulates neuritogenesis.ApoE mimetic ameliorates motor deficit and tissue damage in rat spinal cord injury.SET protein overexpression contributes to paclitaxel resistance in MCF-7/S cells through PI3K/Akt pathway.
P2860
Q24628806-800E77A5-02B9-4F09-A4CE-5D0EAC8192BBQ26778701-8195F34D-E2F7-4263-8D91-4C671A1980A6Q28282855-DA7261E7-0710-4727-82BC-D40A7A3115D3Q30425943-00C5A87A-D31D-438C-8923-F76AB2DF707EQ33517630-0AA1AECE-17C1-4EB9-B0AA-84A0B572C461Q33752988-2E3AF744-8FEA-4278-95AB-7AA6B93B745CQ33960847-6233718E-194A-49C5-8E41-B22CEE074AFBQ34028091-5EFA13E3-835C-4C3B-A55D-01F549C892DEQ34046878-0C54FEDA-4D3E-4995-887B-B1E085EAF828Q34238630-7093F227-FD67-4D2D-83A1-66DAE150DD7AQ34537041-3DC94494-5C0D-4A3D-83AC-B9D57BAB3384Q34680878-A11F2D8C-D1B1-4963-9B48-04F16956032AQ35022139-F0ABD7CD-B61C-4A51-96CC-30CBACC49B43Q35060115-F0172283-1968-4753-A915-C4FC8E64E9A5Q35104765-7AB1F1D4-C1E5-4635-BB63-9E2C9F438915Q35483640-55B10C56-60D7-4818-A4CC-225A2CA887DDQ35927509-E444A55A-10EB-471A-A7AD-94467047B6A9Q36711167-E65F214B-FA10-498E-817D-BD3BB589F430Q36727013-42BB36CA-6C32-4BC3-A6B4-B34EB2A4CE63Q36918114-9BE3C1B6-138A-46B1-B261-4C66ACD724B8Q37060457-468B619D-FE9F-4C83-8063-C883947887FFQ37201603-7F96D79B-4521-4EBB-A184-34AD579BA3D3Q37258296-9816A3BE-6379-4D42-AAFE-DBCCB7A89B65Q37315219-0953AFB8-39CA-4E44-AA7F-B9A907933405Q37343069-C5852564-BDB5-4A8E-B492-2F24E831E686Q37344143-31E7C625-D907-4396-A585-BA418F941366Q37357906-270B19F3-03CE-4BB1-B3C3-941157363C96Q37965590-6E928807-1867-4424-9A20-0FBF5FFD664AQ38613399-39C7C810-552B-41DA-A505-55C78DC5A499Q39062158-BBD98DAC-725D-48B6-8E1F-7AF654495000Q39442352-DF931662-60F9-427F-9CA1-681782B95894Q40998426-DA495860-7DDB-48C0-B82C-C14187F1A167Q41494940-98302F06-C109-4B34-990F-FBFDDC3F8D2DQ41898440-1C3E10BB-1E28-40C3-AF46-B399C5953CA4Q42744992-07CA3F5B-F7A8-41FE-BD04-276A6F98B231Q47125997-6FEC07EF-604F-42B6-8C4F-D959AE27E166Q47619892-30CDB9E5-79A0-4268-9F70-4A81E3EB06EDQ50134122-0F5C5482-875C-4CE7-9472-B9C66C955303Q50224523-86230B6B-813D-4FD6-822B-4F66CD6D3E1FQ51414305-684CF2EB-B062-420E-A70C-E364113C1DE8
P2860
Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Apolipoprotein E-derived pepti ...... e model of multiple sclerosis.
@en
Apolipoprotein E-derived pepti ...... e model of multiple sclerosis.
@nl
type
label
Apolipoprotein E-derived pepti ...... e model of multiple sclerosis.
@en
Apolipoprotein E-derived pepti ...... e model of multiple sclerosis.
@nl
prefLabel
Apolipoprotein E-derived pepti ...... e model of multiple sclerosis.
@en
Apolipoprotein E-derived pepti ...... e model of multiple sclerosis.
@nl
P2093
P356
P1476
Apolipoprotein E-derived pepti ...... e model of multiple sclerosis.
@en
P2093
Daniel T Laskowitz
Feng-Qiao Li
Michael P Vitek
Suzanne E McKenna
P304
P356
10.1124/JPET.106.103671
P407
P577
2006-06-01T00:00:00Z